Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy.

MNGIE Mitochondrial neurogastrointestinal encephalomyopathy biomarker erythrocyte encapsulated thymidine phosphorylase miR-34a-5p miRNA mitochondrial disease outcome measures thymidine phosphorylase

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Apr 2021
Historique:
received: 25 02 2021
revised: 25 03 2021
accepted: 27 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an ultra-rare disease for which there are currently no validated outcome measures for assessing therapeutic intervention efficacy. The aim of this study was to identify a plasma and/or serum microRNA (miRNA) biomarker panel for MNGIE. Sixty-five patients and 65 age and sex matched healthy controls were recruited and assigned to one of four study phases: (i) discovery for sample size determination; (ii) candidate screening; (iii) candidate validation; and (iv) verifying the performance of the validated miRNA panel in four patients treated with erythrocyte-encapsulated thymidine phosphorylase (EE-TP), an enzyme replacement under development for MNGIE. Quantitative PCR (qPCR) was used to profile miRNAs in serum and/or plasma samples collected for the discovery, validation and performance phases, and next generation sequencing (NGS) analysis was applied to serum samples assigned to the candidate screening phase. Forty-one differentially expressed candidate miRNAs were identified in the sera of patients (

Identifiants

pubmed: 33916195
pii: ijms22073681
doi: 10.3390/ijms22073681
pmc: PMC8037498
pii:
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/K025406/1
Pays : United Kingdom
Organisme : Lily Foundation
ID : LILY-2017.18 (APPLICATION 3 - BAX)

Références

J Transl Genet Genom. 2020 Mar 30;4:1-16
pubmed: 32914088
J Biol Chem. 2002 Feb 8;277(6):4128-33
pubmed: 11733540
J Cancer. 2020 Mar 4;11(10):3072-3081
pubmed: 32226522
Orphanet J Rare Dis. 2015 Feb 10;10:16
pubmed: 25757705
J Neurol. 2020 Dec;267(12):3702-3710
pubmed: 32683607
Neuromuscul Disord. 2001 Jan;11(1):7-10
pubmed: 11166160
Nat Genet. 2005 May;37(5):495-500
pubmed: 15806104
Development. 1992 Oct;116(2):369-75
pubmed: 1283735
Genet Mol Res. 2015 Oct 27;14(4):13172-83
pubmed: 26535630
Dev Dyn. 2007 Jan;236(1):60-72
pubmed: 16937373
EMBO J. 2005 Oct 5;24(19):3482-92
pubmed: 16163384
Cancer Res. 2004 Aug 1;64(15):5245-50
pubmed: 15289330
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Cell Death Differ. 2010 Feb;17(2):193-9
pubmed: 19461653
Liver Int. 2020 Sep;40(9):2203-2214
pubmed: 32657505
Adv Exp Med Biol. 2013;774:77-101
pubmed: 23377969
J Mol Histol. 2012 Dec;43(6):669-79
pubmed: 23014974
Clin Chem. 2010 Nov;56(11):1733-41
pubmed: 20847327
J Neurosci Res. 2014 Aug;92(8):1071-7
pubmed: 24648008
Exp Cell Res. 2017 Sep 1;358(1):39-44
pubmed: 28372972
Int J Mol Sci. 2019 Feb 16;20(4):
pubmed: 30781524
Food Chem Toxicol. 2017 Dec;110:229-239
pubmed: 29042291
Intractable Rare Dis Res. 2020 May;9(2):71-78
pubmed: 32494553
Biosci Rep. 2007 Jun;27(1-3):151-63
pubmed: 17549623
EBioMedicine. 2020 Dec;62:103133
pubmed: 33232869
Nat Rev Cancer. 2012 Sep;12(9):613-26
pubmed: 22898542
Neurologist. 2004 Jan;10(1):8-17
pubmed: 14720311
Nature. 1995 Jan 26;373(6512):347-9
pubmed: 7530333
Arch Neurol. 2007 Mar;64(3):435-8
pubmed: 17353390
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W498-504
pubmed: 22649059
J Clin Invest. 2003 Jun;111(12):1913-21
pubmed: 12813027
Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
pubmed: 18158296
Cancer Res. 2019 Mar 1;79(5):941-953
pubmed: 30530815
J Cell Physiol. 2016 Jan;231(1):25-30
pubmed: 26031493
Trends Neurosci. 2009 Apr;32(4):199-206
pubmed: 19268374
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17016-21
pubmed: 17942673
J Clin Med. 2019 Jul 24;8(8):
pubmed: 31344955
Neurogastroenterol Motil. 2009 Jun;21(6):627-31
pubmed: 19368660
FEBS Lett. 2016 Apr;590(7):924-34
pubmed: 26780878
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7
pubmed: 17875987
J Clin Med. 2019 Apr 05;8(4):
pubmed: 30959750
Am J Transl Res. 2017 Dec 15;9(12):5388-5399
pubmed: 29312491
Science. 1999 Jan 29;283(5402):689-92
pubmed: 9924029
Oncotarget. 2015 Feb 28;6(6):3988-4004
pubmed: 25686834
Gastroenterology. 1999 Jul;117(1):140-8
pubmed: 10381920
AJNR Am J Neuroradiol. 2018 Mar;39(3):427-434
pubmed: 29348134
J Mol Neurosci. 2018 Jan;64(1):117-128
pubmed: 29218499
Neurochem Res. 2019 May;44(5):1252-1261
pubmed: 30877521
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Gene. 1997 Mar 10;187(1):75-81
pubmed: 9073069
Int J Mol Sci. 2021 Jan 12;22(2):
pubmed: 33445477
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
J Inherit Metab Dis. 2021 Mar;44(2):376-387
pubmed: 32898308
J Mol Cell Biol. 2014 Jun;6(3):192-7
pubmed: 24868102
Kidney Blood Press Res. 2018;43(2):406-421
pubmed: 29558749
Oncotarget. 2013 Sep;4(9):1399-415
pubmed: 24009080
Neurology. 2006 Oct 24;67(8):1458-60
pubmed: 16971696
Cell Death Differ. 2010 Feb;17(2):236-45
pubmed: 19696787
Bone Marrow Transplant. 2011 Mar;46(3):330-337
pubmed: 20436523
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Nutrients. 2019 Nov 27;11(12):
pubmed: 31783635
J Cereb Blood Flow Metab. 2016 Feb;36(2):387-92
pubmed: 26661155
J Mol Cell Biol. 2011 Feb;3(1):44-50
pubmed: 21278451
Front Genet. 2013 May 24;4:94
pubmed: 23745127
Nucleosides Nucleotides Nucleic Acids. 2018;37(11):618-629
pubmed: 30587073
J Mass Spectrom. 2006 May;41(5):586-92
pubmed: 16498612
Mol Genet Metab. 2020 May;130(1):58-64
pubmed: 32173240
Neurology. 1994 Apr;44(4):721-7
pubmed: 8164833
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Sci Rep. 2017 Feb 01;7:38232
pubmed: 28145431
J Neurol. 2012 Dec;259(12):2699-706
pubmed: 22711161
J Stat Softw. 2011 Mar;39(5):1-13
pubmed: 27065756
BMC Gastroenterol. 2018 Oct 19;18(1):149
pubmed: 30340467
Br J Clin Pharmacol. 2019 May;85(5):893-899
pubmed: 30720885
Am J Med. 2002 Aug 1;113(2):112-9
pubmed: 12133749
J Cell Biol. 2002 Feb 18;156(4):631-42
pubmed: 11854307
Front Pharmacol. 2021 Feb 23;12:614068
pubmed: 33708127
Brain. 2011 Nov;134(Pt 11):3326-32
pubmed: 21933806
Oncotarget. 2017 Nov 21;8(66):110209-110220
pubmed: 29299142
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Mark Mencias (M)

Molecular and Clinical Sciences, St. George's, University of London, London SW17 0RE, UK.

Michelle Levene (M)

Molecular and Clinical Sciences, St. George's, University of London, London SW17 0RE, UK.

Kevin Blighe (K)

Clinical Bioinformatics Research Ltd., London W1B 3HH, UK.

Bridget E Bax (BE)

Molecular and Clinical Sciences, St. George's, University of London, London SW17 0RE, UK.
Molecular and Clinical Sciences, St. George's, University of London, London SW17 0RE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH